<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="publisher-id">IJPharm</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0253-7613</issn>
      <issn pub-type="epub">1998-3751</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24741202</article-id>
      <article-id pub-id-type="pmc">3987199</article-id>
      <article-id pub-id-type="publisher-id">IJPharm-46-232</article-id>
      <article-id pub-id-type="doi">10.4103/0253-7613.129332</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Drug Watch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acute generalized exanthematous pustulosis induced by piroxicam: A case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cherif</surname>
            <given-names>Y.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jallouli</surname>
            <given-names>Moez</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mseddi</surname>
            <given-names>M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Turki</surname>
            <given-names>H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bahloul</surname>
            <given-names>Z.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Internal Medicine, Hedi Chaker University Hospital, Sfax, Tunisia</aff>
      <aff id="aff2"><label>1</label>Department of Dermatology, Hedi Chaker University Hospital, Sfax, Tunisia</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Moez Jallouli, E-mail: <email xlink:href="jallouli5moez@yahoo.fr">jallouli5moez@yahoo.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <volume>46</volume>
      <issue>2</issue>
      <fpage>232</fpage>
      <lpage>233</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>30</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Pharmacology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acute generalized exanthematous pustulosis (AGEP) is a severe adverse cutaneous reaction characterized by an acute episode of sterile pustules over erythematous-edematous skin. The main triggering drugs are antibiotics, mainly beta-lactam and macrolides. Non-steroid anti-inflammatory drugs may rarely be responsible. We describe a case of a woman with AGEP, who presented with generalized pustulosis lesions after the use of piroxicam for renal colic. The diagnosis was confirmed by the clinical and histological correlations and the dermatosis resolved after withdrawal of the drug.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Acute generalized exanthematous pustulosis</kwd>
        <kwd>adverse drug reactions</kwd>
        <kwd>piroxicam</kwd>
        <kwd>pustulosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>Introduction</title>
      <p>Cutaneous adverse drug reactions are estimated to be about 30% of all adverse drug reactions and observed in 2-3% of hospitalized patients.[<xref rid="ref1" ref-type="bibr">1</xref>] The cutaneous drug reaction shows various clinical features and mechanisms.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Acute generalized exanthematous pustulosis (AGEP) is a generalized pustular eruption that is primarily drug-induced in probably more than 90% of case.[<xref rid="ref3" ref-type="bibr">3</xref>] In a few cases infections including cytomegalovirus[<xref rid="ref4" ref-type="bibr">4</xref>] and parvovirus B19,[<xref rid="ref5" ref-type="bibr">5</xref>] chlamydia and mycoplasma pneumoniae[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] have been suspected. A spider bite was recently implicated as a possible cause of AGEP in three patients.[<xref rid="ref8" ref-type="bibr">8</xref>] Although various drugs have been implicated in this condition, there are no reported cases of AGEP caused by oral oxicams in the current literature. We report here a case of AGEP induced by piroxicam.</p>
    </sec>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>This was a case report of a 61-year-old female patient who was admitted to internal medicine department for renal colic. She had no history of psoriasis or any other skin disorder. The patient had a history of longstanding arterial hypertension for 3 years treated with captopril, indapamide, nifedipine and diabetes mellitus for 3 years treated with glibenclamide, glimepiride and dyslipidemia treated with simvastatin. She was given oral piroxicam 20 mg/day by her primary care physician for treatment of renal colic. There were no other medications prior to starting piroxicam. At 4 days after starting oral piroxicam, she developed a generalized itchy eruption consisting of multiple papules that sometimes coalesced to larger and scaly plaques, on a background of widespread erythema with associated multiple 2-3 mm pustules [<xref ref-type="fig" rid="F1">Figure 1</xref>]. The mucus membranes, palms and soles were spared. Nikolsky's sign was negative. The remaining physical examination was normal. Her white blood cell count was 10.8 &#xD7; 10<sup>3</sup>/mm<sup>3</sup>, with a 6.42 &#xD7; 10<sup>3</sup>/mm<sup>3</sup> neutrophil count. The remaining laboratory tests performed were within the normal range: creatinine 61.1 &#x3BC;mol/l, erythrocyte rate sedimentation at 30 mm/h, C-reactive protein 19.48 mg/l and her liver function tests were: Aspartate transaminase 38 U/ml, bilirubin 9 &#x3BC;mol/l and alkaline phosphatase 88 U/ml. A skin biopsy specimen revealed well-developed subcorneal pustules associated with epidermal spongiosis. Scattered neutrophils as well as eosinophils were noted within the dermis (According to the EuroSCAR score, the most of criteria have been met by our patient who had a score of 9). Within a week of piroxicam withdrawal, the patient's lesions gradually began clearing. The patient remained on the same therapies for her arterial hypertension, diabetes mellitus and dyslipidemia.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Multiple papules and pustules that coalesced to larger and scaly plaques</p>
        </caption>
        <graphic xlink:href="IJPharm-46-232-g001"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>AGEP is a rare pustular severe cutaneous adverse reaction that generally presents with an acute edematous erythema and small non-follicular sterile pustules mostly beginning in folds or face and within hours becomes diffuse. Skin symptoms are almost always accompanied by fever (&#x2265;38&#xB0;C) and leukocytosis with a high neurophil count (&#x2265;7000/&#x3BC;l). Other skin symptoms such as marked edema of the face, purpura, blisters and vesicles have been described.[<xref rid="ref3" ref-type="bibr">3</xref>] Additional systemic manifestations include mild eosinophilia, lymphadenopathy, acute renal failure and a mild elevation of liver enzymes.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref9" ref-type="bibr">9</xref>]</p>
      <p>The multinational epidemiological case-control study on severe cutaneous adverse reactions (EuroSCAR-project) has developed and used the well-defined EuroSCAR group criteria to establish the diagnosis of AGEP.[<xref rid="ref3" ref-type="bibr">3</xref>] The accuracy of the EuroSCAR group criteria has been validated.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref9" ref-type="bibr">9</xref>] It allots 0, 1 or 2 points for each of 4 variables of morphology, &#x2212;10, 0, 1, 2 or 3 for each of 5 variables of histological findings. In addition, it assigns &#x2212;4, &#x2212;2, 0 or 1 for each of 5 items of the disease's course. Its involved items yield causality levels of definite with a scale at 8-12 points, probable (5-7 points), possible (1-4 points) and excluded AGEP (0 point).[<xref rid="ref3" ref-type="bibr">3</xref>] The range of the score is between &#x2212;18 and 12. In our case, the EuroSCAR score was 9 and therefore, the case was specified as definite AGEP.</p>
      <p>Histological findings show subcorneal and/or intraepidermal pustules, with pronounced edema in the papillary dermis and a perivascular infiltrate of neutrophils and eosinophils.[<xref rid="ref3" ref-type="bibr">3</xref>]</p>
      <p>A wide spectrum of cutaneous diseases or reactions is associated with pustular eruptions.[<xref rid="ref10" ref-type="bibr">10</xref>] However, the chief differential diagnosis would include pustular psoriasis.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref11" ref-type="bibr">11</xref>]</p>
      <p>Most cases of AGEP have been attributed to drug reactions.[<xref rid="ref3" ref-type="bibr">3</xref>] Roujeau <italic>et al</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] found that 87% of cases resulted from drug reactions. Studies show that antibiotics were the most common drugs implicated (75%), with no attributes to non-steroidal anti-inflammatory drugs (NSAIDs). Furthermore, there is an increasing number of cases caused by anti-fungals.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref11" ref-type="bibr">11</xref>] A study done by Chang <italic>et al</italic>.[<xref rid="ref9" ref-type="bibr">9</xref>] analyzed 16 cases of AGEP with a relatively low association with systemic drugs (62.5%), there was no case of causative NSAIDs. There have been few cases implicating NSAIDs,[<xref rid="ref1" ref-type="bibr">1</xref>] including ibuprofen,[<xref rid="ref13" ref-type="bibr">13</xref>] diclofenac,[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref11" ref-type="bibr">11</xref>] topical bufexamac, naproxen and phenylbutazone.[<xref rid="ref11" ref-type="bibr">11</xref>] As corticosteroids are commonly used in the treatment of severe AGEP; they nevertheless, may trigger severe and rare AGEP.[<xref rid="ref14" ref-type="bibr">14</xref>]</p>
      <p>In this case, the clinical presentation and histology of a skin biopsy were consistent with AGEP. Resolution began without further use of piroxicam, which advocates the diagnosis in retrospect. The other medications (nifedipine, captopril, indapamide, glibenclamide, glimepiride and simvastatin) were continued. This association could have been strengthened by performing patch test with piroxicam.[<xref rid="ref11" ref-type="bibr">11</xref>] Due to the self-limited and benign course of this disease, treatment is usually not necessary except for symptomatic therapy and withdrawal of the culprit drug.[<xref rid="ref8" ref-type="bibr">8</xref>] Some cases have been treated with intravenous hydrocortisone, oral prednisolone or methylprednisolone or topical agents alone.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] Drugs like infliximab were used in an over lop of AGEP-toxic epidermal necrolysis.[<xref rid="ref10" ref-type="bibr">10</xref>] In our case, the withdrawal of piroxicam was sufficient to resolve all clinical features in only 1 week.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turk</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Gunaydin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ertam</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ozturk</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Adverse cutaneous drug reactions among hospitalized patients: Five year surveillance</article-title>
          <source>Cutan Ocul Toxicol</source>
          <year>2013</year>
          <volume>32</volume>
          <fpage>41</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">22812902</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wedi</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Definitions and mechanisms of drug hypersensitivity</article-title>
          <source>Expert Rev Clin Pharmacol</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>539</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">22111682</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sidoroff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Halevy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bavinck</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Vaillant</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Roujeau</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis (AGEP) &#x2013; A clinical reaction pattern</article-title>
          <source>J Cutan Pathol</source>
          <year>2001</year>
          <volume>28</volume>
          <fpage>113</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11168761</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haro-Gabald&#xF3;n</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>S&#xE1;nchez-S&#xE1;nchez-Vizcaino</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ruiz-Avila</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guti&#xE9;rrez-Fern&#xE1;ndez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Linares</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Naranjo-Sintes</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis with cytomegalovirus infection</article-title>
          <source>Int J Dermatol</source>
          <year>1996</year>
          <volume>35</volume>
          <fpage>735</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">8891829</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calistru</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lisboa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Bettencourt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis to amoxicillin associated with parvovirus B19 reactivation</article-title>
          <source>Cutan Ocul Toxicol</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>258</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">22257115</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis associated with asymptomatic <italic>Mycoplasma pneumoniae</italic> infection</article-title>
          <source>Arch Dermatol</source>
          <year>2009</year>
          <volume>145</volume>
          <fpage>848</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19620579</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manzano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guggisberg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hammann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Laubscher</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis: First case associated with a <italic>Chlamydia pneumoniae</italic> infection</article-title>
          <source>Arch Pediatr</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>1230</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">16919427</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidovici</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Pavel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cagnano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rozenman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Halevy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Euro</surname>
              <given-names>SCAR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis following a spider bite: Report of 3 cases</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2006</year>
          <volume>55</volume>
          <fpage>525</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16908368</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia</article-title>
          <source>Acta Derm Venereol</source>
          <year>2008</year>
          <volume>88</volume>
          <fpage>363</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">18709306</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peermohamed</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haber</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: A case report and review of the literature</article-title>
          <source>Arch Dermatol</source>
          <year>2011</year>
          <volume>147</volume>
          <fpage>697</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="pmid">21690532</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speeckaert</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Speeckaert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brochez</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis: An overview of the clinical, immunological and diagnostic concepts</article-title>
          <source>Eur J Dermatol</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>425</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">20542841</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roujeau</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bioulac-Sage</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bourseau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guillaume</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lok</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis. Analysis of 63 cases</article-title>
          <source>Arch Dermatol</source>
          <year>1991</year>
          <volume>127</volume>
          <fpage>1333</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">1832534</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rastogi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Modi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dhawan</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis (ALEP) caused by Ibuprofen. A case report</article-title>
          <source>Br J Oral Maxillofac Surg</source>
          <year>2009</year>
          <volume>47</volume>
          <fpage>132</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">18783858</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziemssen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>B&#xE4;r</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Potential side effect of high-dose corticosteroid relapse treatment: Acute generalized exanthematous pustulosis (AGEP)</article-title>
          <source>Mult Scler</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>275</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">18805845</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
